Min-Sung is a Managing Partner at the Berlin-based Digital Health Ventures (DHV) fund. His international investment experience ranges from early-stage to late-stage. Since 2013, Min-Sung invested in successful digital health companies, including mySugr, NeuroNation, Mimi, Medbelle, hi.health, and Amwell (IPO 2020).
Before joining DHV as Managing Partner, Min-Sung was responsible for the Berlin office of Samsung Catalyst Fund and helped create AllianzX ($3bn assets under management).
Min-Sung studied Management and Business at Witten/Herdecke, Harvard, St. Gallen, and Korea University in Seoul.